Yana Feygin

Prof. Dr. Yana Feygin

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
BWBethany Ann Wattles
Bethany Ann Wattles
KJKahir S. Jawad
Kahir S. Jawad
YFYana Feygin
Yana Feygin
JSJ. Drew Stahl
J. Drew Stahl
NVNavjyot K. Vidwan
Navjyot K. Vidwan
MSMichael J. Smith
Michael J. Smith
Objective: To describe pediatric outpatient visits and antibiotic prescribing during the coronavirus disease 2019 (COVID-19) pandemic. Design: An observational, retrospective control study from January 2019 to October 2021. Setting: Outpatient clinics, including 27 family medicine clinics, 27 pediatric clinics, and 26 urgent or prompt care clinics. Patients: Children aged 0–19 years receiving care in an outpatient setting. Methods: Data were extracted from the electronic health record. The COVID-19 era was defined as April 1, 2020, to October 31, 2021. Virtual visits were identified by coded encounter or visit type variables. Visit diagnoses were assigned using a 3-tier classification system based on appropriateness of antibiotic prescribing and a subanalysis of respiratory visits was performed to compare changes in the COVID-19 era compared to baseline. Results: Through October 2021, we detected an overall sustained reduction of 18.2% in antibiotic prescribing to children. Disproportionate changes occurred in the percentages of antibiotic visits in respiratory visits for children by age, race or ethnicity, practice setting, and prescriber type. Virtual visits were minimal during the study period but did not result in higher rates of antibiotic visits or in-person follow-up visits. Conclusions: These findings suggest that reductions in antibiotic prescribing have been sustained despite increases in outpatient visits. However, additional studies are warranted to better understand disproportionate rates of antibiotic visits.

19 October 2023 in Vaccine
Verified
Journal Article
Closed access
RHRebecca Hart
Rebecca Hart
YFYana Feygin
Yana Feygin
TKTheresa Kluthe
Theresa Kluthe
KQKatherine G. Quinn
Katherine G. Quinn
SRSuchitra Rao
Suchitra Rao
SBShannon H. Baumer-Mouradian
Shannon H. Baumer-Mouradian

18 December 2023 in JAACAP Open
Verified
Journal Article
Open access
WLW. David Lohr
W. David Lohr
KJKahir S. Jawad
Kahir S. Jawad
NWNichole Wood
Nichole Wood
JLJennifer F. Le
Jennifer F. Le
MSMichelle D. Stevenson
Michelle D. Stevenson
DDDeborah Winders Davis
Deborah Winders Davis
To describe and identify factors associated with mental health (MH) readmission rates for youth ages 5 to 17 years discharged between January 2019 and November 2019. This retrospective, cross-sectional analysis using the 2019 Nationwide Readmissions Database identified hospitalizations for patients with a primary diagnosis of an MH condition using the Clinical Classification Software groupings, which are based on ICD-10-CM codes. Various patient characteristics including comorbidities were included in univariate and multivariate analysis to study their association with psychiatric readmission. A 30-day readmission rate of 7.8% was found for the overall sample with significantly higher rates for youth younger than age 15 years. MH comorbidity was a factor in readmission rates; having ≥3 primary MH conditions was associated with higher rates of readmission (adjusted odds ratio [aOR] = 1.20). Significantly higher rates of readmission were noted for several diagnostic groupings including schizophrenia spectrum and other psychotic disorders (aOR = 1.95); bipolar and related disorders (aOR = 1.42); other specified and unspecified mood disorders (aOR = 1.42); disruptive, impulse-control, and conduct disorders (aOR = 1.32); and neurodevelopmental disorders (aOR = 1.23). Having public insurance (aOR=1.28) and a longer length of stay (AOR = 1.71 for ≥15 days) were associated with significantly higher odds of an MH readmission. A concerning number of children admitted for MH conditions in 2019 were readmitted within 30 days (7.8%). Younger children, children with specific MH diagnoses, children with public health insurance, and children with a long initial length of stay have higher odds for readmission and represent a target for prevention and intervention. We worked to ensure that the study questionnaires were prepared in an inclusive way. Diverse cell lines and/or genomic datasets were not available. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented sexual and/or gender groups in science.

17 October 2023 in Health Services Research
Verified
Journal Article
Open access
LCLiza M Creel
Liza M Creel
YFYana Feygin
Yana Feygin
MSMadeline Shipley
Madeline Shipley
DDDeborah W. Davis
Deborah W. Davis
THTiffany Cole Hall
Tiffany Cole Hall
SDScott D. Duncan
Scott D. Duncan
Objective: To describe network structure and alignment across organizations in healthcare, public health, and social services sectors that serve pregnant and parenting women with substance use disorder (SUD) in an urban and a rural community.Data Sources and Study Settings: Two community networks, one urban and one rural with each including a residential substance use treatment program, in Kentucky during 2021.Study Design: Social network analysis measured system collaboration and cross‐sector alignment between healthcare, public health, and social services organizations, applying the Framework for Aligning Sectors. To understand the alignment and structure of each network, we measured network density overall and between sectors, network centralization, and each organization's degree centrality and effective size.Data Collection/Extraction Methods: Computer‐assisted telephone interviews were conducted to document alignment around shared purpose, data, financing, and governance.Principal Findings: On average, overall and cross‐sector network densities in both communities were similar. However, alignment was highest for data sharing and financing in the urban community and for shared purpose and governance in the rural community. Cross‐sector partnerships involving healthcare organizations were more prevalent in the rural county (44% vs. 38% for healthcare/public health, 44% vs. 29% for healthcare/social services), but more prevalent for those involving public health/social services organizations in the urban county (42% vs. 24%). A single healthcare organization had the highest degree centrality (Mdn [IQR] = 26 [26–9.5]) and effective size (Mdn [IQR] = 15.9 [20.6–8.7]) within the rural county. Social services organizations held more central positions in the urban county (degree centrality Mdn [IQR] = 13 [14.8–9.5]; effective size Mdn [IQR] = 10.4 [11.4–7.9]).Conclusions: Cross‐sector alignment may strengthen local capacity for comprehensive SUD care for pregnant and parenting women. Healthcare organizations are key players in cross‐sector partnerships in the rural community, where one healthcare facility holds the central brokerage role. In contrast, public health agencies are key to cross‐sector collaboration with social services in the urban community.

16 August 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
BWBethany Ann Wattles
Bethany Ann Wattles
MSMichael J. Smith
Michael J. Smith
YFYana Feygin
Yana Feygin
KJKahir Jawad
Kahir Jawad
AFAndrea Flinchum
Andrea Flinchum
KSKevin B. Spicer
Kevin B. Spicer
Inappropriate antibiotic prescribing to pediatric Medicaid patients was compared among high-volume and non-high-volume prescribers. High-volume prescribers had a higher percentage of inappropriate prescriptions than non-high-volume prescribers (17.2% versus 15.8%, p = 0.005). Targeting high-volume prescribers for stewardship efforts is a practical approach to reducing outpatient antibiotic prescribing that also captures inappropriate use.

31 May 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Leila GobejishviliLeila Gobejishvili
Leila Gobejishvili
VVVatsalya Vatsalya
Vatsalya Vatsalya
DADiana Veronica Avila
Diana Veronica Avila
YFYana Feygin
Yana Feygin
CMCraig McClain
Craig McClain
SBShirish S Barve
Shirish S Barve
Background: Virtually the entire spectrum of liver disease is observed in association with type 2 diabetes mellitus (T2DM); indeed, T2DM is now the most common cause of liver disease in the U.S. We conducted a pilot study to investigate the relevance of increased microbial translocation and systemic inflammation in the development of liver injury in patients with T2DM. Methods: Patients with T2DM (n = 17) and non-diabetic controls (NDC; n = 11) aged 25–80 yrs. participated in this study. Serum levels of endotoxin, calprotectin, soluble CD14 and CD163, and several inflammatory cytokines were measured. In addition to standard liver injury markers, ALT and AST, novel serum markers of liver injury, keratin 18 (K-18) M30 (apoptosis-associated caspase-cleaved keratin 18), and M65 (soluble keratin 18) were evaluated. Statistical analyses were performed using the Mann–Whitney test to assess differences between study groups. Pearson’s correlation analysis was performed to determine the strength of association between two variables using GraphPad Prism 9.5.0 software. Results: Patients with T2DM had significantly higher levels of sCD14 in comparison to NDC, suggesting an increase in gut permeability, microbial translocation, and monocyte/macrophage activation. Importantly, relevant to the ensuing inflammatory responses, the increase in sCD14 in patients with T2DM was accompanied by a significant increase in sCD163, a marker of hepatic Kupffer cell activation and inflammation. Further, a positive correlation was observed between sCD163 and endotoxin and sCD14 in T2DM patients but not in NDC. In association with these changes, keratin 18 (K-18)-based serum markers (M65 and M30) that reflect hepatocyte death were significantly higher in the T2DM group indicating ongoing liver injury. Notably, both M65 and M30 levels correlated with sCD14 and sCD163, suggesting that immune cell activation and hepatic inflammation may be linked to the development of liver injury in T2DM. Conclusions: These findings suggest that the pathogenic changes in the gut–liver axis, marked by increased microbial translocation, may be a major component in the etiology of hepatocyte inflammation and injury in patients with T2DM. However, larger longitudinal studies, including histological evidence, are needed to confirm these observations.